Allient VP granted 403 restricted shares

Bendre Ashish reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 05/08/2026 - 02:13 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Bendre Ashish reported acquisition or exercise transactions in this Form 4 filing.

Allient Inc. executive Ashish Bendre, VP and Group President, reported a compensation-related equity grant. He received 403 time-based restricted shares of common stock at $77.52 per share under the Company’s 2017 Omnibus Incentive Plan. These restricted shares vest in three equal installments on April 1, 2027, 2028 and 2029.

Following this grant, Bendre directly holds 18,410.975 shares of common stock and indirectly holds 1,155 shares through an ESOP Trust. The filing reflects an equity award rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 403 shares

Grant/Award 1 txn

Insider Bendre Ashish

Role VP and Group President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	403	$77.52	$31K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 18,410.975 shares (Direct); Common Stock — 1,155 shares (Indirect, By ESOP Trust)

Holdings Before and After: Common Stock, 18,007.975 to 18,410.975 shares (Direct)

Footnotes (1)

1. F1. Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.

Key Figures

Restricted shares granted: 403 shares Reported grant price: $77.52/share Direct holdings after grant: 18,410.975 shares +1 more

4 metrics

Restricted shares granted 403 shares Time-based restricted common stock grant to Ashish Bendre

Reported grant price $77.52/share Price per share for the 403 restricted shares

Direct holdings after grant 18,410.975 shares Allient common stock directly held by Bendre after the award

Indirect holdings via ESOP Trust 1,155 shares Allient common stock held indirectly by ESOP Trust

Key Terms

time-based restricted shares, 2017 Omnibus Incentive Plan, ESOP Trust, grant/award acquisition

4 terms

time-based restricted shares financial

"Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan."

Time-based restricted shares are company stock granted to employees or insiders that cannot be sold or fully owned until they unlock after a set period of time. Think of them like a savings account that gradually becomes accessible: they help keep key people tied to the company and can change the total number of tradable shares when they become available, which matters for investor returns and expectations about future selling pressure.

2017 Omnibus Incentive Plan financial

"Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan."

ESOP Trust financial

"total_shares_following_transaction 1155.0000, direct_or_indirect I, nature_of_ownership By ESOP Trust"

grant/award acquisition financial

"transaction_action grant/award acquisition, transaction_code_description Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ashish Bendre report in Allient (ALNT) on this Form 4?

Ashish Bendre reported receiving 403 time-based restricted shares of Allient common stock as an equity award. The grant was made under the company’s 2017 Omnibus Incentive Plan and is structured as compensation, not an open-market stock purchase or sale.

How many Allient (ALNT) shares did Ashish Bendre receive in this equity grant?

He received 403 restricted shares of Allient common stock. These are time-based restricted shares granted as compensation and will vest over three years, rather than shares bought directly in the open market at the reported price per share.

What is the vesting schedule for Ashish Bendre’s Allient (ALNT) restricted shares?

The 403 restricted shares vest one-third on April 1, 2027, one-third on April 1, 2028 and the final third on April 1, 2029. This time-based vesting links the award to continued service over several years.

What price per share is associated with the Allient (ALNT) restricted share grant?

The restricted share grant is reported at $77.52 per share. This figure appears in the Form 4 as the price for the 403 time-based restricted shares, even though the award is compensation rather than an open-market purchase transaction.

How many Allient (ALNT) shares does Ashish Bendre hold after this Form 4?

After the grant, he directly holds 18,410.975 Allient common shares. In addition, he indirectly holds 1,155 shares through an ESOP Trust, reflecting both his personal direct ownership and separate indirect plan-related holdings.

Is Ashish Bendre’s Allient (ALNT) Form 4 transaction a market purchase or sale?

No, the Form 4 reflects a grant of restricted shares as compensation, not a market trade. It is coded as a grant or award acquisition, meaning the company awarded shares under its 2017 Omnibus Incentive Plan subject to future vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bendre Ashish

(Last) (First) (Middle)

C/O ALLIENT INC.

495 COMMERCE DRIVE

(Street)

AMHERST NEW YORK 14228

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALLIENT INC [ ALNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP and Group President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/06/2026		A(1)		403	A	$77.52	18,410.975	D
Common Stock								1,155	I	By ESOP Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.

	/s/ Michael C. Donlon, Attorney-in-Fact for Ashish Bendre	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)